Connected or Disconnected: Is your digital strategy a 'side project' or a 'strategic pillar'?

Pharma’s digital presence is expanding quickly. You can see it in the number of platforms being used, the volume of content going out, the steady push toward more “engagement.” But when you take a step back, the picture feels… less certain.

What’s actually working?
What’s just activity dressed up as progress?
And where does digital really sit when decisions are made at a strategic level?

These aren’t always easy questions to answer. Or maybe they’re just not asked often enough, at least not openly.

That’s what this conversation set out to explore.

We brought together Nashlyn Jangooraj (Strategy Enablement Manager), Phumlani Mancapha (Commercial Leadership Expert in Pharmaceutical Sales, Managing Director, MM Group), and Louise Claassen (Human–Technology Futures Specialist, Co-Founder & Managing Director, ORBmersive), hosted by Nitesh Vallabh (Head of Business Solutions, EMGuidance), for a discussion that leans away from polished narratives and into something a bit more honest. Less about presenting a finished view, more about unpacking what’s being seen on the ground. What’s working, what’s not, and where there’s still some uncertainty.